Browse > Article

Oncogenesis and Genetic Screening of Medullary Thyroid Carcinoma  

Shin, Dong-Yeob (Department of Internal Medicine, Yonsei University College of Medicine, Division of Endocrinology)
Noh, Tae-Woong (Department of Internal Medicine, Yonsei University College of Medicine, Division of Endocrinology)
Lee, Eun-Jig (Department of Internal Medicine, Yonsei University College of Medicine, Division of Endocrinology)
Publication Information
Korean Journal of Head & Neck Oncology / v.24, no.2, 2008 , pp. 151-154 More about this Journal
Keywords
Multiple endocrine neoplasia; Oncogene; Medullary thyroid carcinoma;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-5671   DOI
2 Carter MT, Yome JL, Marcil MN, Martin CA, Vanhorne JB, Mulligan LM. Conservation of RET proto-oncogene splicing variants and implications for RET isoform function. Cytogenet Cell Genet. 2001;95:169-176   DOI   ScienceOn
3 Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science. 1995;267:381-383   DOI   ScienceOn
4 Skinner MA, Moley JA, Dilley WG, Owzar K, Debenedetti MK, Wells SA, Jr. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med. 2005;353:1105-1113   DOI   ScienceOn
5 Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 1994;367:380-383   DOI   ScienceOn
6 Block MA, Jackson CE, Greenawald KA, Yott JB, Tashjian AH, Jr. Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications. Arch Surg. 1980;115:142-148   DOI   ScienceOn
7 Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, et al. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab. 2007;92:4725-4729   DOI
8 Kouvaraki MA, Shapiro SE, Perrier ND, Cote GJ, Gagel RF, Hoff AO, et al. RET proto-oncogene: a review and update of genotype- phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid. 2005;15:531-544   DOI   ScienceOn
9 Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell. 1985;42: 581-588   DOI   ScienceOn
10 Ichihara M, Murakumo Y, Takahashi M. RET and neuroendocrine tumors. Cancer Lett. 2004;204:197-211   DOI   ScienceOn
11 Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Miyauchi A, et al. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma. J Hum Genet. 1998;43:101-106   DOI   ScienceOn
12 Drosten M, Putzer BM. Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy. Nat Clin Pract Oncol. 2006;3:564-574   DOI   ScienceOn
13 Arighi E, Borrello MG, Sariola H. RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev. 2005; 16:441-467   DOI   ScienceOn
14 Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 1993;2:851-856   DOI
15 Kebebew E, Tresler PA, Siperstein AE, Duh QY, Clark OH. Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: a report of three cases and review of the literature. Thyroid. 1999;9:127-131   DOI
16 Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA. 1996;276:1575-1579   DOI